Followers | 38 |
Posts | 4010 |
Boards Moderated | 0 |
Alias Born | 11/09/2016 |
Saturday, December 16, 2017 7:31:30 PM
There is no way for big pharma to replace that pipe line fast enough without acquisitions of companies who have already who have already completed the discovery work and are in the process of clinical trials.
It is interesting that this company has a 50 plus million dollar LCF and has a current value of under 1 million as well as drugs in clinical trials.
Tax loss selling will be wrapped up on the 26th of December.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM